INVO Fertility (IVF) 2nd Annual Lytham Partners Healthcare Investor Summit summary

Company overview and mission

• Focuses on fertility care, operating clinics and leveraging innovative technology.

• Operates three clinics and is acquiring a fourth in Indianapolis.

• Dual mission: provide patient care and advance fertility technology.

• INVOcell device is FDA-cleared and used in company and third-party clinics.

Market landscape and industry trends

• U.S. fertility market estimated at $5–$7 billion annually, with about 460 clinics.

• Steady market growth, but high treatment costs limit patient access.

• Recent government policies aim to improve affordability and drive demand.

• Industry increasingly focused on efficiency and expanding clinic networks.

Growth strategy and operational initiatives

• Pursues both organic growth and acquisitions to scale operations.

• Organic growth driven by outreach, new services, and increased patient flow.

• Acquisition pipeline robust, with Indianapolis deal nearing completion.

• Long-term growth includes building new clinics, as done in Birmingham and Atlanta.